Literature DB >> 24434015

[Cardiovascular involvement in Behçet's disease].

A-C Desbois1, B Wechsler2, P Cluzel3, G Helft4, D Boutin2, J-C Piette2, P Cacoub1, D Saadoun5.   

Abstract

Vascular involvement is a common complication of Behçet's disease (BD) and affects up to 40% of BD patients. These complications worsen the prognosis of BD. The concept of vasculo-Behçet has been adopted for cases in which vascular complications dominate the clinical features. Vascular manifestations affect particularly young men, during the first years following onset of the disease. Venous complications are the most frequent vascular complications, affecting 14 to 40% of BD patients. Superficial and deep lower limb thrombosis is the most frequent venous complications but one third of venous thrombosis concern large vessels (such as cerebral venous thrombosis, pulmonary embolism, and inferior or superior vena cava, etc.). Budd-Chiari syndrome is the worst prognostic factor increasing mortality by 9 times. Arterial complications (2 to 17% of BD patients) include aneurysms and occlusions/stenosis. Main locations of arterial lesions are aortic (abdominal and thoracic), femoral, pulmonary and iliac arteries. Aneurysms are the most severe arterial complications, particularly pulmonary aneurysms associated with a high risk of massive bleeding. Cardiac complications (up to 6% of BD patients) include pericarditis, endocardial lesions (aortic regurgitation and less often mitral insufficiency), myocardial lesions (myocardial infarction, myocarditis and endomyocardial fibrosis) and intracardiac thrombosis (right ventricle and atrium). Coronary lesions complicated to myocardial infarction are the most severe cardiac complications. Treatment is based on corticosteroids and immunosuppressive drugs. The use of anticoagulation in venous thrombosis is still controversial.
Copyright © 2014. Published by Elsevier SAS.

Entities:  

Keywords:  Atteinte cardiaque; Atteinte vasculaire; Behçet's disease; Cardiac involvement; Maladie de Behçet; Vascular involvement; Vascularite; Vasculitis

Mesh:

Substances:

Year:  2014        PMID: 24434015     DOI: 10.1016/j.revmed.2013.12.002

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  10 in total

1.  Atherogenic index of plasma may be strong predictor of subclinical atherosclerosis in patients with Behçet disease.

Authors:  E Cure; A Icli; A Ugur Uslu; R Aydoğan Baykara; D Sakiz; M Ozucan; F Yavuz; S Arslan; M Cumhur Cure; A Kucuk
Journal:  Z Rheumatol       Date:  2017-04       Impact factor: 1.372

2.  Potential Utility of Oral Mucosal Capillaroscopy as an Indicator of Microvascular Damage in Behçet Disease: A Preliminary Study.

Authors:  Abdullah Demirbaş; Ömer Faruk Elmas; Gözde Ulutaş Demirbaş; Mustafa Atasoy; Ümit Türsen; Torello Lotti
Journal:  Dermatol Pract Concept       Date:  2021-09-01

3.  Behçet's Disease: Pulmonary Aneurysm Resolution with Oral Therapy and HLA B72 Allele Association.

Authors:  Clarissa de Albuquerque Botura; Luiz Eduardo Bersani-Amado; Antônio Rubens Zacarias-Júnior; Sueli Donizete Boreli; Naiene Gomes Gordo Stecca; Bruno Ambrósio da Rocha; Roberto Kenji Nakamura Cuman; Ciomar Aparecida Bersani-Amado
Journal:  Clin Med Res       Date:  2018-04-02

4.  Behçet's disease physiopathology: a contemporary review.

Authors:  Mohamad J Zeidan; David Saadoun; Marlene Garrido; David Klatzmann; Adrien Six; Patrice Cacoub
Journal:  Auto Immun Highlights       Date:  2016-02-12

5.  Behcet's disease manifesting as esophageal variceal bleeding: A case report.

Authors:  Wen-Xing Xie; Hai-Tao Jiang; Guo-Qing Shi; Li-Na Yang; Hong Wang
Journal:  World J Clin Cases       Date:  2021-04-26       Impact factor: 1.337

6.  Epidemiological, clinical, and therapeutic characteristics of Behçet's disease: a monocentric study in Tunisia.

Authors:  Fatma Daoud; Imène Rachdi; Mehdi Somai; Anissa Zaouak; Houda Hammami; Meriem Ouederni; Rym Maamouri; Hana Zoubeidi; Molka Tougorti; Jihène Ksouri; Besma Ben Dhaou; Zohra Aydi; Samy Fenniche; Monia Cheour; Fatma Boussema
Journal:  Pan Afr Med J       Date:  2021-09-03

7.  An Abdominal Aortic Pseudoaneurysm Revealing Behçet's Disease.

Authors:  Zineb Baba; Ahmed Mougui; Imane El Bouchti
Journal:  Case Rep Vasc Med       Date:  2022-01-27

8.  Vasculitis damage index in Behçet's disease.

Authors:  Fatema T Elgengehy; Sherif M Gamal; Nesreen Sobhy; Ibrahem Siam; Ahmed M Soliman; Ghada W Elhady; Tamer A Gheita
Journal:  Adv Rheumatol       Date:  2021-06-09

9.  [Aneurysm of the ascending aorta associated with massive aortic regurgitation: rare and serious complication of Behçet disease].

Authors:  Abdelkhalek Chetoui; Hicham El Malki; Mohamed Bahous; Jaafar Rhissassi; Rochde Sayah; Mohamed Laaroussi
Journal:  Pan Afr Med J       Date:  2015-06-03

10.  Endovascular treatment with in-vitro fenestration and sac filling technique for ruptured thoracoabdominal aortic aneurysm with Behcet's disease.

Authors:  Shibo Xia; Chao Song; Lei Zhang; Wenping Hu; Haiyan Li; Yu Shen; Qingsheng Lu
Journal:  J Cardiothorac Surg       Date:  2020-08-17       Impact factor: 1.637

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.